AbbottIndia-CompanyUpdate4Jul25-Research Post navigation Previous Previous post: ABBOTT INDIA is immune from the US tariff woes & can sustain the ROCE of 45%. Buy for target price of ₹40128 (16% upside): BOB Caps Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Current ye@r * Leave this field empty